Balancing benefit and risk in TSH management of DTC

被引：1
|
作者：
Verburg, Frederik A. [1 ]
Luster, Markus [1 ]
机构：
[1] Univ Hosp Marburg, Dept Nucl Med, Marburg, Germany
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2018年 / 14卷 / 03期
关键词：
DIFFERENTIATED THYROID-CARCINOMA; THERAPY; CANCER; AXIS;
D O I：
10.1038/nrendo.2018.1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TSH-suppressive therapy and the increased risk of cardiovascular disease in patients with differentiated thyroid cancer (DTC) was previously reported. A recent study by Pajamaki and colleagues found that patients with DTC have a higher risk of atrial fibrillation but a lower all-cause cardiovascular death rate. This study offers insights into this effect.
引用
收藏
页码：136 / U81
页数：2
相关论文
共 50 条
  • [21] Prevention of angle-closure glaucoma: balancing risk and benefit
    Foster, Paul J.
    Ng, Wai Siene
    Nolan, Winifred P.
    Tanner, Luke
    Gazzard, Gus
    Day, Alex C.
    Sanders, Roshini
    Foot, Barny
    Salmon, John F.
    Azuara-Blanco, Augusto
    EYE, 2022, 36 (12) : 2229 - 2231
  • [22] Intensive care: balancing risk and benefit to facilitate informed decisions
    Gross, Jamie
    Williams, Barry
    Fade, Premila
    Brett, Stephen J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [23] Rethinking osteoporosis: Balancing risk and benefit in diagnosis, prevention, and treatment
    Smith, Alice
    Shaw, Brittany
    Laliberte, Danielle
    Langston, Jennifer
    Bushardt, Reamer L.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (08): : 20 - 27
  • [24] Balancing risk and benefit in patients with atrial fibrillation: the GARFIELD-AF risk score
    Fox, K.
    Virdone, S.
    Pieper, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3577 - 3577
  • [25] Balancing benefit discounts
    Glassman, Gary
    VETERINARY ECONOMICS, 2007, 48 (06): : 14 - 14
  • [26] Copper management strategies in obligate bacterial symbionts: balancing cost and benefit
    Rivera-Millot, Alex
    Harrison, Luke B.
    Veyrier, Frederic J.
    EMERGING TOPICS IN LIFE SCIENCES, 2024, 8 (01) : 29 - 35
  • [27] Balancing risk and benefit in early-stage classical Hodgkin lymphoma
    Broeckelmann, Paul J.
    Sasse, Stephanie
    Engert, Andreas
    BLOOD, 2018, 131 (15) : 1666 - 1678
  • [28] Precision Genetic Therapies: Balancing Risk and Benefit in Patients with Heart Failure
    Johnston, Jamie R.
    Adler, Eric D.
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (09) : 973 - 983
  • [29] Patient Decision Making for Asymptomatic Renal Calculi: Balancing Benefit and Risk
    Sarkissian, Carl
    Noble, Mark
    Li, Jianbo
    Monga, Manoj
    UROLOGY, 2013, 81 (02) : 236 - 240
  • [30] Bioresorbable stents: A balancing act between thrombosis risk and potential benefit
    Wiebe J.
    Der Kardiologe, 2017, 11 (6): : 448 - 449
12345